The Centers for Disease Control and Prevention has awarded Emergent BioSolutions Inc. a $26 million contract to continue to supply a medical treatment to the government.
{iframe}http://thedailyrecord.com/2018/02/28/maryland-emergent-biosolutions-vigiv-cdc/{/iframe}